Greenleaf Trust Reduces Position in HCA Healthcare, Inc. (NYSE:HCA)

Greenleaf Trust trimmed its stake in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 4.7% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 4,793 shares of the company’s stock after selling 239 shares during the period. Greenleaf Trust’s holdings in HCA Healthcare were worth $806,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Brown Brothers Harriman & Co. boosted its position in HCA Healthcare by 12.8% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 413 shares of the company’s stock valued at $69,000 after buying an additional 47 shares during the period. Glassman Wealth Services raised its holdings in shares of HCA Healthcare by 28.7% in the 2nd quarter. Glassman Wealth Services now owns 233 shares of the company’s stock valued at $39,000 after purchasing an additional 52 shares in the last quarter. Cetera Investment Advisers raised its holdings in shares of HCA Healthcare by 1.3% in the 1st quarter. Cetera Investment Advisers now owns 4,499 shares of the company’s stock valued at $1,128,000 after purchasing an additional 56 shares in the last quarter. DGS Capital Management LLC raised its holdings in shares of HCA Healthcare by 2.8% in the 2nd quarter. DGS Capital Management LLC now owns 2,279 shares of the company’s stock valued at $383,000 after purchasing an additional 62 shares in the last quarter. Finally, Motley Fool Asset Management LLC raised its stake in shares of HCA Healthcare by 0.8% during the 1st quarter. Motley Fool Asset Management LLC now owns 8,132 shares of the company’s stock worth $2,038,000 after acquiring an additional 64 shares in the last quarter. 65.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 8,332 shares of the stock in a transaction dated Friday, October 28th. The shares were sold at an average price of $222.58, for a total value of $1,854,536.56. Following the completion of the sale, the senior vice president now directly owns 40,652 shares in the company, valued at $9,048,322.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, SVP Kathryn A. Torres sold 2,000 shares of the firm’s stock in a transaction dated Monday, October 24th. The shares were sold at an average price of $203.30, for a total transaction of $406,600.00. Following the completion of the sale, the senior vice president now directly owns 20,372 shares in the company, valued at $4,141,627.60. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 8,332 shares of the firm’s stock in a transaction dated Friday, October 28th. The stock was sold at an average price of $222.58, for a total transaction of $1,854,536.56. Following the sale, the senior vice president now owns 40,652 shares of the company’s stock, valued at $9,048,322.16. The disclosure for this sale can be found here. Insiders have sold a total of 30,170 shares of company stock valued at $6,700,630 over the last ninety days. Corporate insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HCA shares. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday. Stephens cut their price target on shares of HCA Healthcare from $230.00 to $220.00 and set an “overweight” rating on the stock in a research note on Monday, October 24th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $249.00 to $239.00 and set an “outperform” rating on the stock in a research note on Monday, October 24th. Oppenheimer cut their price target on shares of HCA Healthcare from $255.00 to $235.00 and set an “outperform” rating on the stock in a research note on Monday, October 24th. Finally, Raymond James cut their price target on shares of HCA Healthcare from $250.00 to $230.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 25th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $235.10.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $237.28 on Thursday. The company’s fifty day moving average price is $208.86 and its 200 day moving average price is $202.31. HCA Healthcare, Inc. has a 1 year low of $164.47 and a 1 year high of $279.02. The company has a market capitalization of $67.08 billion, a PE ratio of 13.41, a price-to-earnings-growth ratio of 1.91 and a beta of 1.70. The company has a debt-to-equity ratio of 87.46, a quick ratio of 1.17 and a current ratio of 1.38.

HCA Healthcare (NYSE:HCAGet Rating) last posted its quarterly earnings data on Friday, October 21st. The company reported $3.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.94 by ($0.01). The company had revenue of $14.97 billion for the quarter, compared to analysts’ expectations of $15 billion. HCA Healthcare had a net margin of 8.99% and a negative return on equity of 118,732.40%. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same period in the previous year, the business earned $4.57 earnings per share. On average, research analysts predict that HCA Healthcare, Inc. will post 16.96 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Wednesday, December 14th will be issued a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a yield of 0.94%. The ex-dividend date is Tuesday, December 13th. HCA Healthcare’s payout ratio is 12.66%.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.